ArticleNeurology(R) neuroimmunology & neuroinflammation2024

Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides.

Lara Dungan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.